ALEMBIC CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

hydrochlorothiazide, Quantity: 12.5 mg; candesartan cilexetil, Quantity: 16 mg

Commercializzato da:

Alembic Pharmaceuticals Australia Pty Ltd

INN (Nome Internazionale):

Candesartan cilexetil,Hydrochlorothiazide

Forma farmaceutica:

Tablet, uncoated

Composizione:

Excipient Ingredients: lactose monohydrate; magnesium stearate; carmellose calcium; macrogol 8000; hyprolose; maize starch; iron oxide red

Via di somministrazione:

Oral

Confezione:

30 tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

The treatment of hypertension. Treatment should not be initiated with these fixed dose combinations.

Dettagli prodotto:

Visual Identification: Light pink, oval, biconvex uncoated mottled tablets debossed with 'L3' & '02' on either side of break line on one side & break line on one other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 6 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2012-12-05